Clinical Trials Directory

Trials / Conditions / Primary Effusion Lymphoma

Primary Effusion Lymphoma

8 registered clinical trials studyying Primary Effusion Lymphoma — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudy of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019
Schrödinger, Inc.Phase 1
Active Not RecruitingAssessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective
NCT04742387
National Cancer Institute (NCI)—
Active Not RecruitingNivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lympho
NCT03038672
National Cancer Institute (NCI)Phase 2
Active Not RecruitingLenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-ass
NCT02911142
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
NCT02652715
Mayo ClinicN/A
WithdrawnStudy of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
NCT02228512
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedVorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-C
NCT01193842
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingSpecimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions
NCT00006518
National Cancer Institute (NCI)—